Sirtuin 1 (SIRT1): a potential immunohistochemical marker and therapeutic target in soft tissue neoplasms with myoid differentiation
Authors:
- Brendan C. DicksonBDBrendan C. Dickson
- Nicole D. RiddleNRNicole D. Riddle
- John S. BrooksJBJohn S. Brooks
- Theresa L. PashaTPTheresa L. Pasha
- Paul J. ZhangPZPaul J. Zhang
- 1 June 2013
- journal article
- Published by Elsevier in Human Pathology
- Vol. 44 (6) , 1125-1130
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- SirT1 Is an Inhibitor of Proliferation and Tumor Formation in Colon CancerJournal of Biological Chemistry, 2009
- SIRT1 Promotes Differentiation of Normal Human KeratinocytesJournal of Investigative Dermatology, 2009
- Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocationProceedings of the National Academy of Sciences, 2008
- sirt1-null mice develop an autoimmune-like conditionExperimental Cell Research, 2008
- Association of SIRT1 gene variation with visceral obesityHuman Genetics, 2008
- A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cellsBiochemical and Biophysical Research Communications, 2008
- Glucose Restriction Inhibits Skeletal Myoblast Differentiation by Activating SIRT1 through AMPK-Mediated Regulation of NamptDevelopmental Cell, 2008
- The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer GrowthPLOS ONE, 2008
- Phosphorylation of HuR by Chk2 Regulates SIRT1 ExpressionMolecular Cell, 2007
- Sir2 Flexes Its MuscleDevelopmental Cell, 2003